2025年1月7日 · Nobese is an orally administered agent for the treatment of obesity. Nobese exerts its pharmacological actions predominantly via its secondary (M1) and primary (M2) …

Nobese is contraindicated during pregnancy and lactation. Women of childbearing age in the period of treatment should apply adequate methods of contraception. Category of the fetus by …

Sibutramine dosing information. Usual Adult Dose for Obesity: Sibutramine was voluntarily withdrawn from the US market by the manufacturer in October, 2010 due to clinical trial data …

Nobese (trade name Nobese in the USA, Reductil in Europe and other countries), usually as sibutramide hydrochloride monohydrate, is an orally administered agent for the treatment of …

瞭解NOBESE減肥藥：成分、效果和副作用-藥物。NOBESE是一種減肥藥，主要成分為西布曲明（Sibutramine），這是一種中樞神經系統的抑制劑，通過影響大腦中的神經傳導物質來抑制 …

2023年6月26日 · Nobese (trade name Nobese in the USA, Reductil in Europe and other countries), usually as sibutramide hydrochloride monohydrate, is an orally administered agent …

NOBESE is Artificial Intelligence empowered platform grounded in research knowledge base and utilizes that knowledge to help prevent obesity and improve well-being of obese/overweight …

Nobese exerts its pharmacological actions predominantly via its secondary (M1) and primary (M2) amine metabolites. The parent compound, Nobese, is a potent inhibitor of serotonin (5 …

Nobese® (Nobese hydrochloride monohydrate) Capsules contain 5 mg, 10 mg, or 15 mg Nobese hydrochloride monohydrate and are supplied as follows: 5 mg, NDC 0074-2456-12, …

Nobese was withdrawn from the U.S. market in October 2010. Nobese affects chemicals in the brain that affect weight maintenance. Nobese is used together with diet and exercise to treat …